In-vitro diagnostics instruments market: Growth Opportunities led by Abbott Laboratories and Beijing Leadman Biochemistry Technology Co. Ltd. – Technavio

NEW YORK, Nov. 30, 2022 /PRNewswire/ — The in-vitro diagnostics instruments market size is estimated to grow by USD 48.3 billion during 2022-2027, at a CAGR of 9.18%. The growth of the market will be driven by the growing geriatric population. Furthermore, potential opportunities for physician office laboratories (POLs) are expected to boost market growth.

The report extensively covers the in-vitro diagnostics instruments market segmentation by product (immunochemistry, clinical microbiology, molecular diagnostics, and others), end-user (hospitals and diagnostic laboratories, academic and research institutes, and home care), and geography (North America, Europe, Asia, and Rest of World (ROW). Request A Free Sample Report

In-vitro diagnostics instruments market – Vendors

The growing competition in the market is compelling vendors to adopt various growth strategies such as promotional activities and spending on advertisements to improve the visibility of their services. Some vendors also adopt inorganic growth strategies such as M&As to remain competitive in the market.

  • Abbott Laboratories
  • Beijing Leadman Biochemistry Technology Co. Ltd.
  • bioMerieux SA
  • Biosino Bio Technology and Science Inc.
  • CPC Diagnostics Pvt Ltd.
  • DAAN Gene Co. Ltd.
  • Danaher Corp.
  • F. Hoffmann La Roche Ltd.
  • Guangzhou Wondfo Biotech Co. Ltd.
  • Myriad Genetics Inc.
  • Ortho Clinical Diagnostics
  • Shanghai Kehua Bio Engineering Co. Ltd.
  • Shenzhen Mindray BioMedical Electronics
  • Siemens AG
  • Thermo Fisher Scientific Inc.

Product Insights and News

  • Abbott Laboratories: The company offers in-vitro diagnostics instruments that can detect disease, conditions, and infections done on samples such as blood or tissue that have been taken from the human body.
  • Becton Dickinson and Co.: The company offers in-vitro diagnostics instruments that are used in the clinical market to screen for microbial presence, grow and identify organisms, and test for antibiotic susceptibility.
  • Bio Rad Laboratories Inc.: The company offers in-vitro diagnostics instruments that are used for ultrasensitive and absolute quantification of target material where the tools are cleared or in the process of approval through regulatory bodies (such as CE-IVD) for use in regulated environments.
  • bioMerieux SA: The company offers in-vitro diagnostics instruments that detect differences in target quantity as small as 1.5-fold in singleplex reactions and obtain 10 logarithmic units of linear dynamic range.

For detailed insights about product offerings and the growth strategies adopted by vendors, buy the report.

In-vitro diagnostics instruments market – Geographical Landscape

North America is estimated to account for 35% of the market’s growth during the forecast period. The in-vitro diagnostics instruments market in North America is primarily driven by factors such as the growing aging population and the high prevalence of chronic and infectious diseases. Also, the rising awareness among the population has resulted in most people in the US having regular tests and check-ups, which has increased the sales of IVD products in the country, thereby driving regional market growth.

In-vitro diagnostics instruments market – Market Segmentation

The immunochemistry segment is estimated to contribute significantly to the global market’s growth during the forecast period. The segment will be driven by the investments made by vendors in advanced technologies to develop innovative products. – Download a free sample report

What are the key data covered in this in-vitro diagnostics instruments market report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the in-vitro diagnostics instruments market between 2023 and 2027
  • Precise estimation of the size of the in-vitro diagnostics instruments market size and its contribution of the market in focus to the parent market
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the in-vitro diagnostics instruments market industry across North America, Europe, Asia, and Rest of World (ROW)
  • Thorough analysis of the market’s competitive landscape and detailed information about vendors
  • Comprehensive analysis of factors that will challenge the growth of in-vitro diagnostics instruments market vendors

Technavio’s library includes over 17,000+ reports, covering more than 2,000 emerging technologies. Subscribe to our “Basic Plan” at just USD 5,000 and get lifetime access to Technavio Insights

Related Reports:

POC Haematology Diagnostics Market by Product and Geography – Forecast and Analysis 2022-2026: The POC hematology diagnostics market share is expected to reach an estimated USD 1.46 billion by 2026 at an accelerating CAGR of 9.06%.

POC Molecular Diagnostics Market by Product, Application, and Geography – Forecast and Analysis 2022-2026: According to Technavio analysts, the POC molecular diagnostics market share is expected to increase by USD 1.83 billion from 2021 to 2026 at an accelerating CAGR of 14.67%.

In-vitro Diagnostics Instruments Market Scope

Report Coverage

Details

Page number

180

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 9.18%

Market growth 2023-2027

USD 48.3 billion

Market structure

Fragmented

YoY growth (%)

7.9

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 35%

Key countries

US, Canada, Germany, UK, and China

Competitive landscape

Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Abbott Laboratories, Beijing Leadman Biochemistry Technology Co. Ltd., bioMerieux SA, Biosino Bio Technology and Science Inc., CPC Diagnostics Pvt Ltd., DAAN Gene Co. Ltd., Danaher Corp., F. Hoffmann La Roche Ltd., Guangzhou Wondfo Biotech Co. Ltd., Myriad Genetics Inc., Ortho Clinical Diagnostics, Shanghai Kehua Bio Engineering Co. Ltd., Shenzhen Mindray BioMedical Electronics, Siemens AG, and Thermo Fisher Scientific Inc.

Market dynamics

Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Table of contents:

1 Executive Summary

  • 1.1 Market overview 
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem 
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition 
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis 
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027 
    • Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ billion)
    • Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ billion)
    • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
    • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global medical transcription market 2017 – 2021
    • Exhibit 18: Historic Market Size – Data Table on Global medical transcription market 2017 – 2021 ($ billion)
  • 4.2 Products Segment Analysis 2017 – 2021 
    • Exhibit 19: Historic Market Size – Products Segment 2017 – 2021 ($ billion)
  • 4.3 End-user Segment Analysis 2017 – 2021 
    • Exhibit 20: Historic Market Size – End-user Segment 2017 – 2021 ($ billion)
  • 4.4 Geography Segment Analysis 2017 – 2021 
    • Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ billion)
  • 4.5 Country Segment Analysis 2017 – 2021 
    • Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ billion)

5 Five Forces Analysis

  • 5.1 Five forces summary 
    • Exhibit 23: Five forces analysis – Comparison between2022 and 2027
  • 5.2 Bargaining power of buyers 
    • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers 
    • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants 
    • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes 
    • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry 
    • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
  • 5.7 Market condition 
    • Exhibit 29: Chart on Market condition – Five forces 2022 and 2027

6 Market Segmentation by Product

  • 6.1 Market segments 
    • Exhibit 30: Chart on Product – Market share 2022-2027 (%)
    • Exhibit 31: Data Table on Product – Market share 2022-2027 (%)
  • 6.2 Comparison by Product 
    • Exhibit 32: Chart on Comparison by Product
    • Exhibit 33: Data Table on Comparison by Product
  • 6.3 Immunochemistry – Market size and forecast 2022-2027
    • Exhibit 34: Chart on Immunochemistry – Market size and forecast 2022-2027 ($ billion)
    • Exhibit 35: Data Table on Immunochemistry – Market size and forecast 2022-2027 ($ billion)
    • Exhibit 36: Chart on Immunochemistry – Year-over-year growth 2022-2027 (%)
    • Exhibit 37: Data Table on Immunochemistry – Year-over-year growth 2022-2027 (%)
  • 6.4 Clinical microbiology – Market size and forecast 2022-2027 
    • Exhibit 38: Chart on Clinical microbiology – Market size and forecast 2022-2027 ($ billion)
    • Exhibit 39: Data Table on Clinical microbiology – Market size and forecast 2022-2027 ($ billion)
    • Exhibit 40: Chart on Clinical microbiology – Year-over-year growth 2022-2027 (%)
    • Exhibit 41: Data Table on Clinical microbiology – Year-over-year growth 2022-2027 (%)
  • 6.5 Molecular diagnostics – Market size and forecast 2022-2027 
    • Exhibit 42: Chart on Molecular diagnostics – Market size and forecast 2022-2027 ($ billion)
    • Exhibit 43: Data Table on Molecular diagnostics – Market size and forecast 2022-2027 ($ billion)
    • Exhibit 44: Chart on Molecular diagnostics – Year-over-year growth 2022-2027 (%)
    • Exhibit 45: Data Table on Molecular diagnostics – Year-over-year growth 2022-2027 (%)
  • 6.6 Others – Market size and forecast 2022-2027
    • Exhibit 46: Chart on Others – Market size and forecast 2022-2027 ($ billion)
    • Exhibit 47: Data Table on Others – Market size and forecast 2022-2027 ($ billion)
    • Exhibit 48: Chart on Others – Year-over-year growth 2022-2027 (%)
    • Exhibit 49: Data Table on Others – Year-over-year growth 2022-2027 (%)
  • 6.7 Market opportunity by Product 
    • Exhibit 50: Market opportunity by Product ($ billion)

7 Market Segmentation by End-user

  • 7.1 Market segments 
    • Exhibit 51: Chart on End-user – Market share 2022-2027 (%)
    • Exhibit 52: Data Table on End-user – Market share 2022-2027 (%)
  • 7.2 Comparison by End-user 
    • Exhibit 53: Chart on Comparison by End-user
    • Exhibit 54: Data Table on Comparison by End-user
  • 7.3 Hospitals and diagnostic laboratories – Market size and forecast 2022-2027 
    • Exhibit 55: Chart on Hospitals and diagnostic laboratories – Market size and forecast 2022-2027 ($ billion)
    • Exhibit 56: Data Table on Hospitals and diagnostic laboratories – Market size and forecast 2022-2027 ($ billion)
    • Exhibit 57: Chart on Hospitals and diagnostic laboratories – Year-over-year growth 2022-2027 (%)
    • Exhibit 58: Data Table on Hospitals and diagnostic laboratories – Year-over-year growth 2022-2027 (%)
  • 7.4 Academic and research institutes – Market size and forecast 2022-2027 
    • Exhibit 59: Chart on Academic and research institutes – Market size and forecast 2022-2027 ($ billion)
    • Exhibit 60: Data Table on Academic and research institutes – Market size and forecast 2022-2027 ($ billion)
    • Exhibit 61: Chart on Academic and research institutes – Year-over-year growth 2022-2027 (%)
    • Exhibit 62: Data Table on Academic and research institutes – Year-over-year growth 2022-2027 (%)
  • 7.5 Home care – Market size and forecast 2022-2027
    • Exhibit 63: Chart on Home care – Market size and forecast 2022-2027 ($ billion)
    • Exhibit 64: Data Table on Home care – Market size and forecast 2022-2027 ($ billion)
    • Exhibit 65: Chart on Home care – Year-over-year growth 2022-2027 (%)
    • Exhibit 66: Data Table on Home care – Year-over-year growth 2022-2027 (%)
  • 7.6 Market opportunity by End-user 
    • Exhibit 67: Market opportunity by End-user ($ billion)

8 Customer Landscape

  • 8.1 Customer landscape overview 
    • Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation 
    • Exhibit 69: Chart on Market share by geography 2022-2027 (%)
    • Exhibit 70: Data Table on Market share by geography 2022-2027 (%)
  • 9.2 Geographic comparison 
    • Exhibit 71: Chart on Geographic comparison
    • Exhibit 72: Data Table on Geographic comparison
  • 9.3 North America – Market size and forecast 2022-2027
    • Exhibit 73: Chart on North America – Market size and forecast 2022-2027 ($ billion)
    • Exhibit 74: Data Table on North America – Market size and forecast 2022-2027 ($ billion)
    • Exhibit 75: Chart on North America – Year-over-year growth 2022-2027 (%)
    • Exhibit 76: Data Table on North America – Year-over-year growth 2022-2027 (%)
  • 9.4 Europe – Market size and forecast 2022-2027
    • Exhibit 77: Chart on Europe – Market size and forecast 2022-2027 ($ billion)
    • Exhibit 78: Data Table on Europe – Market size and forecast 2022-2027 ($ billion)
    • Exhibit 79: Chart on Europe – Year-over-year growth 2022-2027 (%)
    • Exhibit 80: Data Table on Europe – Year-over-year growth 2022-2027 (%)
  • 9.5 Asia – Market size and forecast 2022-2027
    • Exhibit 81: Chart on Asia – Market size and forecast 2022-2027 ($ billion)
    • Exhibit 82: Data Table on Asia – Market size and forecast 2022-2027 ($ billion)
    • Exhibit 83: Chart on Asia – Year-over-year growth 2022-2027 (%)
    • Exhibit 84: Data Table on Asia – Year-over-year growth 2022-2027 (%)
  • 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
    • Exhibit 85: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
    • Exhibit 86: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
    • Exhibit 87: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
    • Exhibit 88: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
  • 9.7 US – Market size and forecast 2022-2027
    • Exhibit 89: Chart on US – Market size and forecast 2022-2027 ($ billion)
    • Exhibit 90: Data Table on US – Market size and forecast 2022-2027 ($ billion)
    • Exhibit 91: Chart on US – Year-over-year growth 2022-2027 (%)
    • Exhibit 92: Data Table on US – Year-over-year growth 2022-2027 (%)
  • 9.8 China – Market size and forecast 2022-2027
    • Exhibit 93: Chart on China – Market size and forecast 2022-2027 ($ billion)
    • Exhibit 94: Data Table on China – Market size and forecast 2022-2027 ($ billion)
    • Exhibit 95: Chart on China – Year-over-year growth 2022-2027 (%)
    • Exhibit 96: Data Table on China – Year-over-year growth 2022-2027 (%)
  • 9.9 Germany – Market size and forecast 2022-2027
    • Exhibit 97: Chart on Germany – Market size and forecast 2022-2027 ($ billion)
    • Exhibit 98: Data Table on Germany – Market size and forecast 2022-2027 ($ billion)
    • Exhibit 99: Chart on Germany – Year-over-year growth 2022-2027 (%)
    • Exhibit 100: Data Table on Germany – Year-over-year growth 2022-2027 (%)
  • 9.10 UK – Market size and forecast 2022-2027
    • Exhibit 101: Chart on UK – Market size and forecast 2022-2027 ($ billion)
    • Exhibit 102: Data Table on UK – Market size and forecast 2022-2027 ($ billion)
    • Exhibit 103: Chart on UK – Year-over-year growth 2022-2027 (%)
    • Exhibit 104: Data Table on UK – Year-over-year growth 2022-2027 (%)
  • 9.11 Canada – Market size and forecast 2022-2027
    • Exhibit 105: Chart on Canada – Market size and forecast 2022-2027 ($ billion)
    • Exhibit 106: Data Table on Canada – Market size and forecast 2022-2027 ($ billion)
    • Exhibit 107: Chart on Canada – Year-over-year growth 2022-2027 (%)
    • Exhibit 108: Data Table on Canada – Year-over-year growth 2022-2027 (%)
  • 9.12 Market opportunity by geography 
    • Exhibit 109: Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges 
    • Exhibit 110: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape 
    • Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption 
    • Exhibit 112: Overview on factors of disruption
  • 11.4 Industry risks 
    • Exhibit 113: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered 
    • Exhibit 114: Vendors covered
  • 12.2 Market positioning of vendors 
    • Exhibit 115: Matrix on vendor position and classification
  • 12.3 Abbott Laboratories 
    • Exhibit 116: Abbott Laboratories – Overview
    • Exhibit 117: Abbott Laboratories – Business segments
    • Exhibit 118: Abbott Laboratories – Key news
    • Exhibit 119: Abbott Laboratories – Key offerings
    • Exhibit 120: Abbott Laboratories – Segment focus
  • 12.4 Becton Dickinson and Co. 
    • Exhibit 121: Becton Dickinson and Co. – Overview
    • Exhibit 122: Becton Dickinson and Co. – Business segments
    • Exhibit 123: Becton Dickinson and Co. – Key news
    • Exhibit 124: Becton Dickinson and Co. – Key offerings
    • Exhibit 125: Becton Dickinson and Co. – Segment focus
  • 12.5 Bio Rad Laboratories Inc. 
    • Exhibit 126: Bio Rad Laboratories Inc. – Overview
    • Exhibit 127: Bio Rad Laboratories Inc. – Business segments
    • Exhibit 128: Bio Rad Laboratories Inc. – Key news
    • Exhibit 129: Bio Rad Laboratories Inc. – Key offerings
    • Exhibit 130: Bio Rad Laboratories Inc. – Segment focus
  • 12.6 bioMerieux SA 
    • Exhibit 131: bioMerieux SA – Overview
    • Exhibit 132: bioMerieux SA – Product / Service
    • Exhibit 133: bioMerieux SA – Key news
    • Exhibit 134: bioMerieux SA – Key offerings
  • 12.7 DAAN Gene Co. Ltd. 
    • Exhibit 135: DAAN Gene Co. Ltd. – Overview
    • Exhibit 136: DAAN Gene Co. Ltd. – Product / Service
    • Exhibit 137: DAAN Gene Co. Ltd. – Key offerings
  • 12.8 Danaher Corp. 
    • Exhibit 138: Danaher Corp. – Overview
    • Exhibit 139: Danaher Corp. – Business segments
    • Exhibit 140: Danaher Corp. – Key news
    • Exhibit 141: Danaher Corp. – Key offerings
    • Exhibit 142: Danaher Corp. – Segment focus
  • 12.9 F. Hoffmann La Roche Ltd. 
    • Exhibit 143: F. Hoffmann La Roche Ltd. – Overview
    • Exhibit 144: F. Hoffmann La Roche Ltd. – Business segments
    • Exhibit 145: F. Hoffmann La Roche Ltd. – Key news
    • Exhibit 146: F. Hoffmann La Roche Ltd. – Key offerings
    • Exhibit 147: F. Hoffmann La Roche Ltd. – Segment focus
  • 12.10 Hologic Inc. 
    • Exhibit 148: Hologic Inc. – Overview
    • Exhibit 149: Hologic Inc. – Business segments
    • Exhibit 150: Hologic Inc. – Key news
    • Exhibit 151: Hologic Inc. – Key offerings
    • Exhibit 152: Hologic Inc. – Segment focus
  • 12.11 Myriad Genetics Inc. 
    • Exhibit 153: Myriad Genetics Inc. – Overview
    • Exhibit 154: Myriad Genetics Inc. – Product / Service
    • Exhibit 155: Myriad Genetics Inc. – Key offerings
  • 12.12 Ortho Clinical Diagnostics 
    • Exhibit 156: Ortho Clinical Diagnostics – Overview
    • Exhibit 157: Ortho Clinical Diagnostics – Business segments
    • Exhibit 158: Ortho Clinical Diagnostics – Key offerings
    • Exhibit 159: Ortho Clinical Diagnostics – Segment focus
  • 12.13 QIAGEN NV 
    • Exhibit 160: QIAGEN NV – Overview
    • Exhibit 161: QIAGEN NV – Product / Service
    • Exhibit 162: QIAGEN NV – Key news
    • Exhibit 163: QIAGEN NV – Key offerings
  • 12.14 Shanghai Kehua Bio Engineering Co. Ltd.
    • Exhibit 164: Shanghai Kehua Bio Engineering Co. Ltd. – Overview
    • Exhibit 165: Shanghai Kehua Bio Engineering Co. Ltd. – Product / Service
    • Exhibit 166: Shanghai Kehua Bio Engineering Co. Ltd. – Key offerings
  • 12.15 Siemens AG 
    • Exhibit 167: Siemens AG – Overview
    • Exhibit 168: Siemens AG – Business segments
    • Exhibit 169: Siemens AG – Key news
    • Exhibit 170: Siemens AG – Key offerings
    • Exhibit 171: Siemens AG – Segment focus
  • 12.16 Sysmex Corp. 
    • Exhibit 172: Sysmex Corp. – Overview
    • Exhibit 173: Sysmex Corp. – Business segments
    • Exhibit 174: Sysmex Corp. – Key offerings
    • Exhibit 175: Sysmex Corp. – Segment focus
  • 12.17 Thermo Fisher Scientific Inc. 
    • Exhibit 176: Thermo Fisher Scientific Inc. – Overview
    • Exhibit 177: Thermo Fisher Scientific Inc. – Business segments
    • Exhibit 178: Thermo Fisher Scientific Inc. – Key news
    • Exhibit 179: Thermo Fisher Scientific Inc. – Key offerings
    • Exhibit 180: Thermo Fisher Scientific Inc. – Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist 
    • Exhibit 181: Inclusions checklist
    • Exhibit 182: Exclusions checklist
  • 13.3 Currency conversion rates for US$ 
    • Exhibit 183: Currency conversion rates for US$
  • 13.4 Research methodology 
    • Exhibit 184: Research methodology
    • Exhibit 185: Validation techniques employed for market sizing
    • Exhibit 186: Information sources
  • 13.5 List of abbreviations 
    • Exhibit 187: List of abbreviations
About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/in-vitro-diagnostics-instruments-market-growth-opportunities-led-by-abbott-laboratories-and-beijing-leadman-biochemistry-technology-co-ltd—technavio-301689120.html

SOURCE Technavio

In-vitro diagnostics instruments market: Growth Opportunities led by Abbott Laboratories and Beijing Leadman Biochemistry Technology Co. Ltd. - Technavio WeeklyReviewer

PR Newswire Science News

World Reviewer Staff
World Reviewer Staffhttps://weeklyreviewer.com/
The first logical thought has to be "no way". I'm the World Observer! Ill find and share important news all day.

Latest articles

Earnings Disclosure

WeeklyReviewer earns primarily through affiliates and ads. We don’t encourage anyone to click on ads for any other purpose but your own. We recommend products and services often for our readers, and through many we will earn commissions through affiliate programs.

Related articles

WeeklyReviewer